A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2001
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083510A1 29 human secreted proteins
11/08/2001	WO2001083489A1 THIENO[2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS
11/08/2001	WO2001083479A2 Process for the preparation of pyrazolopyridine derivatives
11/08/2001	WO2001083454A1 Benzosuberonylpiperidine compounds as analgesics
11/08/2001	WO2001083450A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	WO2001083445A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/08/2001	WO2001083434A2 P-(sulfonyl)-aryl and heteroaryls amines
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001083425A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001	WO2001082973A2 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
11/08/2001	WO2001082968A1 Cell proliferation inhibitors
11/08/2001	WO2001082953A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
11/08/2001	WO2001082952A2 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS
11/08/2001	WO2001082951A1 Treatment of damaged connective tissue
11/08/2001	WO2001082938A2 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate
11/08/2001	WO2001082924A1 Phosphate transport inhibitors
11/08/2001	WO2001082923A1 Estrogen receptor modulators
11/08/2001	WO2001082919A2 Methods of and compounds for inhibiting calpains
11/08/2001	WO2001082911A2 TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING CLIOQUINOL
11/08/2001	WO2001082899A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
11/08/2001	WO2001068070A8 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
11/08/2001	WO2001044242A9 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases
11/08/2001	WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001030383A3 Medicament in order to induce tolerance
11/08/2001	WO2000074666A3 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
11/08/2001	WO2000017133A3 Lta4 hydrolase inhibitors
11/08/2001	US20010039350 Suitable for prophylaxis of diseases involving interleukin-1 beta such as septic shock, leukemia, hepatits, muscular degeneration, HIV infections, or degenerative joint diseases
11/08/2001	US20010039285 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/08/2001	US20010039274 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease
11/08/2001	US20010039273 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
11/08/2001	US20010039268 New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
11/08/2001	US20010039038 Novel glucosaminidase
11/08/2001	EP1144348A3 Lta 4? hydrolase inhibitors
11/08/2001	CA2414296A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2414290A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2407799A1 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	CA2407797A1 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
11/08/2001	CA2407785A1 Use of .alpha.-msh and epo for preventing or treating ischemic conditions
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407669A1 Treatment of damaged connective tissue
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2405832A1 P-(sulfonyl)aryl and heteroaryls
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	CA2403901A1 29 human secreted proteins
11/08/2001	CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001	EP1152243A1 DIagnosis of Sjögren's syndrome, systemic lupus erythematosis, and scleroderma via detection of anti-retroviral antibodies
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1151752A2 Method for inhibiting bone resorption
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1151067A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
11/07/2001	EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001	EP1150982A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND I$g(k)-A$g(a)
11/07/2001	EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
11/07/2001	EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
11/07/2001	EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150953A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150716A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
11/07/2001	EP1150691A2 Novel antisense inhibition of rad51
11/07/2001	EP1150690A1 Chemical compounds
11/07/2001	EP1150689A1 Chemical compounds
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP1150569A1 Method for reducing hip joint laxity
11/07/2001	EP1150564A1 Inositol derivatives for inhibiting superoxide anion production
11/07/2001	CN1321157A Substd. imidazo [1,2] azines as selective inhibitors of COX-2
11/07/2001	CN1321151A Chemical compounds
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1321091A Method of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
11/07/2001	CN1320445A Chinese-medicinal pill for treating rheumatoid arthritis
11/07/2001	CN1320436A Medicine for treating hyperosteogeny
11/07/2001	CN1320434A Liquor infusion of dittany bark
11/07/2001	CN1320429A Medical liquor for treating injury
11/07/2001	CN1074286C Exterior-applied powder medicine for treating rheumatism and rheumatoid diseases and its preparing process
11/06/2001	US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001	US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants
11/06/2001	US6313298 Spiro-indolines as Y5 receptor antagonists
11/06/2001	US6313270 DbpB
11/06/2001	US6313180 Steroid compounds having contraceptive and anti-osteoporosis activity
11/06/2001	US6313174 Aminobenzophenones as inhibitors of interleukin and TNF
11/06/2001	US6313168 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313140 Method of treatment using certain growth-hormone secret agogues
11/06/2001	US6313123 Acetylenic sulfonamide thiol tace inhibitors
11/06/2001	US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/06/2001	US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001	US6313116 Phosphodiesterase inhibitors
11/06/2001	US6312693 Antibodies against human CD40
11/03/2001	CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof

1 ... 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 ... 820